Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Sebaceous glands can heal and regenerate after injury using their own stem cells and help from hair follicle cells.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Early development of hair, teeth, and glands involves specific signaling pathways and cellular interactions.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Key genes linked to hair growth and cancer were identified in hairless mice.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

Zebrafish need MYC and FGF to regenerate inner ear hair cells.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Blocking JAK-STAT signaling can lead to hair growth.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.